About DrugCard
DrugCard is a Healthcare company based in Tallinn (Estonia) founded in 2020. It operates as a drug pharmacovigilance solutions are provided for pharmaceutical industries. DrugCard has raised $288.35 thousand across 3 funding rounds from investors including Google, Farmak and New Nordic Ventures. Its chief executive is Dmytro Horilyk. Its focus areas include HealthTech, Life Sciences Tech, GRC Solutions and Pharmacovigilance. Its legal entity is DRUGCARDS OÜ. Its competitors include Beijing Dongxie Network, biologit, Sentrx, My Meds & Me and Advera Health and 4 more; 3 of its 9 listed competitors have raised funding.
Company details
DrugCard was founded in 2020 in Tallinn, Estonia, within the pharmaceutical sector. Software solutions are offered to support pharmacovigilance processes, including legal compliance management, data analysis, and AI-enabled decision-making tools. Pharmacovigilance services are also extended to organizations to aid in regulatory adherence and risk assessment across global operations.
- Headquarters Tallinn, Estonia
- SectorsHealthcare
- Website drug-card.io
- Social LinkedIn Facebook
- Legal Name Drugcards Oü
- Total Equity Funding$288.35K (USD)
in 3 rounds
- InvestorsGoogle
& 3 more
Funding Insights of DrugCard
DrugCard has successfully raised a total of $288.35K across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $288,346
- Total Rounds 3
- First Round $288,346
(Dec 2021)
- Investors Count 4
All 3 funding rounds of DrugCard with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2023 | – | Seed | – | New Nordic Ventures | – |
| Mar 2022 | – | Grant | – | – | |
| Dec 2021 | $288,346 | Seed | – | Think Bigger Capital, Farmak | – |
4 investors in total: 4 institutional.
Investors in DrugCard
DrugCard has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Google, Farmak and New Nordic Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Seed-stage investments are made in Eastern European enterprise software startups. | 2021 | newnordic.vc | Latvia | |
- | – | thinkbigger.vc | - | |
A technology company offering products and services, including search engine, cloud computing, advertising, email, productivity software, and more | 1998 | google.com | Mountain View, United States | |
Pharmaceutical drugs and medical devices are manufactured in full cycle. | 1991 | farmak.ua | Kyiv, Ukraine |
Investor details for DrugCard
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of DrugCard
6 people are tracked at DrugCard (4 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Dmytro Horilyk | CEO | Leadership |
Christina Kiselova | Head Of Partnerships And Sales | Leadership |
Miroslav Demchun | Chief Technology Officer | Leadership |
Artem Horilyk | Chief Product Officer, Head Of PV | Leadership |
Ivan Savchenko | PHP Developer Symfony | Team |
Rostyslav Siarkevych | Executive Account Manager | Team |
Complete people profiles for DrugCard
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of DrugCard
3 dated milestones of DrugCard across 3 years, from founding to its latest funding, stage changes and deals.
- Founded DrugCard is founded.
- Funding First funding round of $288K.
- Funding Latest funding round, Seed,.
Competitors of DrugCard
DrugCard has 9 listed competitors in our database, 3 of them funded. They include Beijing Dongxie Network, biologit, Sentrx, My Meds & Me and Advera Health, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dongxitech.com | 2017 | Beijing, China | – | – | AI-based pharmacovigilance platform is developed for report analysis and monitoring. | |
| biologit.com | 2021 | Dublin, Ireland | $1.09M | – | AI-based solutions for drug pharmacovigilance are provided. | |
| sentrx.com | 1995 | Little Falls, United States | – | – | Specialized pharmacovigilance software and services are developed and provided. | |
| mymedsandme.com | 2012 | London, United Kingdom | $3.15M | 26 | Adverse events and product quality are captured for life sciences. | |
| adverahealth.com | 2010 | Santa Rosa, United States | $4.7M | – | Provider of a SaaS based regulatory data analysis and pharmacovigilance platform for life science industry | |
| novemberresearch.com | 2003 | Oakland, United States | – | 5 | Pharmacovigilance software and services are provided for medical vigilance. | |
| insife.com | 2017 | Copenhagen, Denmark | – | – | Pharmacovigilance consulting services are provided to pharma, biotech, and agencies. | |
| ibluebutton.com | 2011 | Del Mar, United States | – | – | Mobile app for accessing health records from government programs and providers securely. | |
| pharmpool.com | 2014 | Tel Aviv, Israel | – | – | Offers a medication adherence app that analyzes drug effects. |
Detailed competitors of DrugCard
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of DrugCard
The website of DrugCard (drug-card.io) receives about 4.1K visits a month.
- Monthly visits4.1K
▼ 22.6% vs previous month
Websites whose visitors overlap most with DrugCard. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
themodelbuilders.co.uk | themodelbuilders.co.uk | 100% | – | #2,273,528 | – |
transatlanticnotes.com | transatlanticnotes.com | 97% | – | #10,753,366 | – |
ukmodels.co.uk | ukmodels.co.uk | 87% | – | #578,720 | – |
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as DrugCard (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Drugcard
Complete news archive for DrugCard
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DrugCard
DrugCard was founded in 2020 and raised its 1st funding round 1 year after it was founded.
DrugCard is headquartered in Tallinn, Estonia.
Dmytro Horilyk is the current CEO of DrugCard.
DrugCard is a funded company, having raised a total of $288.35K across 3 funding rounds to date. The company's 1st funding round was a Seed of $288.35K, raised on Dec 2021.
DrugCard was founded in 2020 in Tallinn, Estonia, within the pharmaceutical sector. Software solutions are offered to support pharmacovigilance processes, including legal compliance management, data analysis, and AI-enabled decision-making tools. Pharmacovigilance services are also extended to organizations to aid in regulatory adherence and risk assessment across global operations.
DrugCard's top competitors include biologit, Sentrx and My Meds & Me.
DrugCard has 4 investors. Key investors include Google, Farmak, New Nordic Ventures, and Think Bigger Capital.
DrugCard operates through Drugcards Oü.